Anh Nhat Tran1, Kiera Walker1, David G Harrison2, Wei Chen2, James Mobley3, Lauren Hocevar1, James R Hackney4, Randee S Sedaka5, Jennifer S Pollock5, Matthew S Goldberg6, Dolores Hambardzumyan7, Sara J Cooper8, Yancey Gillespie9, Anita B Hjelmeland1. 1. Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama. 2. Division of Clinical Pharmacology, Vanderbilt University, Nashville, Tennessee. 3. Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama. 4. Division of Neuropathology, University of Alabama at Birmingham, Birmingham, Alabama. 5. Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama. 6. Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama. 7. Department of Pediatrics, Emory University, Atlanta, Georgia. 8. HudsonAlpha Institute for Biotechnology, Huntsville, Alabama. 9. Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
Background: Depending on the level, differentiation state, and tumor stage, reactive nitrogen and oxygen species inhibit or increase cancer growth and tumor initiating cell maintenance. The rate-limiting enzyme in a pathway that can regulate reactive species production but has not been thoroughly investigated in glioblastoma (GBM; grade IV astrocytoma) is guanosine triphosphate (GTP) cyclohydrolase 1 (GCH1). We sought to define the role of GCH1 in the regulation of GBM growth and brain tumor initiating cell (BTIC) maintenance. Methods: We examined GCH1 mRNA and protein expression in patient-derived xenografts, clinical samples, and glioma gene expression datasets. GCH1 levels were modulated using lentiviral expression systems, and effects on cell growth, self-renewal, reactive species production, and survival in orthotopic patient-derived xenograft models were determined. Results: GCH1 was expressed in GBMs with elevated but not exclusive RNA and protein levels in BTICs in comparison to non-BTICs. Overexpression of GCH1 in GBM cells increased cell growth in vitro and decreased survival in an intracranial GBM mouse model. In converse experiments, GCH1 knockdown with short hairpin RNA led to GBM cell growth inhibition and reduced self-renewal in association with decreased CD44 expression. GCH1 was critical for controlling reactive species balance, including suppressing reactive oxygen species production, which mediated GCH1 cell growth effects. In silico analyses demonstrated that higher GCH1 levels in glioma patients correlate with higher glioma grade, recurrence, and worse survival. Conclusions: GCH1 expression in established GBMs is pro-tumorigenic, causing increased growth due, in part, to promotion of BTIC maintenance and suppression of reactive oxygen species.
Background: Depending on the level, differentiation state, and tumor stage, reactive nitrogen and oxygen species inhibit or increase cancer growth and tumor initiating cell maintenance. The rate-limiting enzyme in a pathway that can regulate reactive species production but has not been thoroughly investigated in glioblastoma (GBM; grade IV astrocytoma) is guanosine triphosphate (GTP) cyclohydrolase 1 (GCH1). We sought to define the role of GCH1 in the regulation of GBM growth and brain tumor initiating cell (BTIC) maintenance. Methods: We examined GCH1 mRNA and protein expression in patient-derived xenografts, clinical samples, and glioma gene expression datasets. GCH1 levels were modulated using lentiviral expression systems, and effects on cell growth, self-renewal, reactive species production, and survival in orthotopic patient-derived xenograft models were determined. Results:GCH1 was expressed in GBMs with elevated but not exclusive RNA and protein levels in BTICs in comparison to non-BTICs. Overexpression of GCH1 in GBM cells increased cell growth in vitro and decreased survival in an intracranial GBM mouse model. In converse experiments, GCH1 knockdown with short hairpin RNA led to GBM cell growth inhibition and reduced self-renewal in association with decreased CD44 expression. GCH1 was critical for controlling reactive species balance, including suppressing reactive oxygen species production, which mediated GCH1 cell growth effects. In silico analyses demonstrated that higher GCH1 levels in gliomapatients correlate with higher glioma grade, recurrence, and worse survival. Conclusions: GCH1 expression in established GBMs is pro-tumorigenic, causing increased growth due, in part, to promotion of BTIC maintenance and suppression of reactive oxygen species.
Authors: Eduard H Panosyan; Dan R Laks; Michael Masterman-Smith; Jack Mottahedeh; William H Yong; Timothy F Cloughesy; Jorge A Lazareff; Paul S Mischel; Theodore B Moore; Harley I Kornblum Journal: Pediatr Blood Cancer Date: 2010-10 Impact factor: 3.167
Authors: Janel E Le Belle; Nicolas M Orozco; Andres A Paucar; Jonathan P Saxe; Jack Mottahedeh; April D Pyle; Hong Wu; Harley I Kornblum Journal: Cell Stem Cell Date: 2011-01-07 Impact factor: 24.633
Authors: Lisa A Ridnour; Douglas D Thomas; Christopher Switzer; Wilmarie Flores-Santana; Jeffrey S Isenberg; Stefan Ambs; David D Roberts; David A Wink Journal: Nitric Oxide Date: 2008-04-22 Impact factor: 4.427
Authors: E Singer; J Judkins; N Salomonis; L Matlaf; P Soteropoulos; S McAllister; L Soroceanu Journal: Cell Death Dis Date: 2015-01-15 Impact factor: 8.469
Authors: Simranjit X Singh; Rui Yang; Kristen Roso; Landon J Hansen; Changzheng Du; Lee H Chen; Paula K Greer; Christopher J Pirozzi; Yiping He Journal: Biomedicines Date: 2022-03-23
Authors: Anh Nhat Tran; Alex M Dussaq; Timothy Kennell; Christopher D Willey; Anita B Hjelmeland Journal: BMC Bioinformatics Date: 2019-09-09 Impact factor: 3.169